These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10094925)

  • 1. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis.
    Albini A; Florio T; Giunciuglio D; Masiello L; Carlone S; Corsaro A; Thellung S; Cai T; Noonan DM; Schettini G
    FASEB J; 1999 Apr; 13(6):647-55. PubMed ID: 10094925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Somatostatinergic control of Kaposi's sarcoma growth through the inhibition of angiogenesis].
    Corsaro A; Thellung S; Villa V; Arena S; Noonan D; Albini A; Schettini G; Florio T
    Minerva Endocrinol; 2001 Dec; 26(4):273-6. PubMed ID: 11782715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.
    Florio T; Morini M; Villa V; Arena S; Corsaro A; Thellung S; Culler MD; Pfeffer U; Noonan DM; Schettini G; Albini A
    Endocrinology; 2003 Apr; 144(4):1574-84. PubMed ID: 12639942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine.
    Albini A; Morini M; D'Agostini F; Ferrari N; Campelli F; Arena G; Noonan DM; Pesce C; De Flora S
    Cancer Res; 2001 Nov; 61(22):8171-8. PubMed ID: 11719447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
    Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins.
    Thornton M; Barkley L; Mason JC; Shaunak S
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2528-33. PubMed ID: 10508038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
    Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B
    Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
    Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
    J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate.
    Dell'Eva R; Pfeffer U; Vené R; Anfosso L; Forlani A; Albini A; Efferth T
    Biochem Pharmacol; 2004 Dec; 68(12):2359-66. PubMed ID: 15548382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.
    Popkov M; Jendreyko N; McGavern DB; Rader C; Barbas CF
    Cancer Res; 2005 Feb; 65(3):972-81. PubMed ID: 15705898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth.
    Pfeffer U; Bisacchi D; Morini M; Benelli R; Minghelli S; Vacca A; Noonan DM; Albini A
    Endocrinology; 2002 Aug; 143(8):3114-21. PubMed ID: 12130577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of CD40 favors the growth and vascularization of Kaposi's sarcoma.
    Biancone L; Cantaluppi V; Boccellino M; Del Sorbo L; Russo S; Albini A; Stamenkovic I; Camussi G
    J Immunol; 1999 Dec; 163(11):6201-8. PubMed ID: 10570312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
    Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
    Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
    Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
    J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells.
    Arora N; Masood R; Zheng T; Cai J; Smith DL; Gill PS
    Cancer Res; 1999 Jan; 59(1):183-8. PubMed ID: 9892205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
    Marginean A; Sharma-Walia N
    Transl Res; 2015 Aug; 166(2):111-33. PubMed ID: 25814167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.